AA

Anju Agarwal

Active Director Director DIN 01198397
DIN 01198397 First appointment Dec 2000 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2000
Shareholding value •••• Premium profile

About Anju Agarwal

Data last updated:

Anju Agarwal is a Director at Maks Pharmaceuticals Private Limited (since 2000). The company operates in Chemicals. Maks Pharmaceuticals Private Limited reported revenue of ₹19.7 Lakh (FY 2025).

DIN 01198397
Primary Designation Director
Industry Chemicals
First Appointment 25 Dec 2000
Oldest Company Age 28 yrs
Largest company Maks Pharmaceuticals Private Limited · ₹19.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maks Pharmaceuticals Private Limited U24232DL1998PTC093355
Director25 Dec 20001998₹19.7 Lakh (FY 2025)Active

Board colleagues of Anju Agarwal

NameDINCompanyDesignation
Madhusudan Agarwal01198402Maks Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Maks Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anju Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anju Agarwal

Anju Agarwal currently holds 1 directorship: Maks Pharmaceuticals Private Limited (Director, since 25 Dec 2000, revenue ₹19.7 Lakh (FY 2025)).

Anju Agarwal was first appointed on 25 Dec 2000 as Director at Maks Pharmaceuticals Private Limited.

The current boards of Anju Agarwal's companies include Madhusudan Agarwal (Maks Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available